All In MedTech

Device Trial Radar · NCT05830578

Clinical Validation of the Electrocardiogram Measurement

Clinical Validation of the Electrocardiogram Measurement and Atrial Fibrillation Detection Function of a Wearable Smartwatch

Last checked: Nov 19, 2026Latest source record: Nov 24, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

602

Planned (sponsor's estimate)

Start

Dec 1, 2023

Primary completion

Jun 30, 2024

Study completion Dec 30, 2024

Sponsor

Lead sponsor
Taipei Medical University HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 26, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Atrial fibrillation (AFib) is a common type of cardiac arrhythmia in clinical practice, affecting millions of people worldwide. Early detection and treatment of atrial fibrillation are crucial in preventing serious complications such as stroke and heart failure. In recent years, with the flourishing development of wearable devices and mobile technology, electrocardiogram (ECG) measurement applications embedded in smartwatches have gradually become a non-invasive and convenient method for heart rate monitoring. However, the accuracy of these devices has not yet been fully determined. This study aims to verify the ECG measurement and atrial fibrillation detection function of the ASUS Blood Pressure Monitor/Oximeter/ECG Monitor. The accuracy of the ECG application in detecting atrial fibrillation and measuring ECG will be evaluated by comparison with standard 12-lead ECGs.

Conditions

  • Atrial Fibrillation

Interventions

  • ASUS Blood Pressure Monitor/Oximeter/ECG MonitorDevice

    The ASUS Blood Pressure Monitor/Oximeter/ECG Monitor analyzes data collected by the integrated electrical sensors on a ASUS Vivowatch to generate an ECG waveform similar to a Lead I, calculate average heart rate, and provide a rhythm classification to the user for a given 30 second session. When a user opens the ECG App while wearing the ASUS VivoWatch on one wrist and places the finger of the opposite hand on the digital crown, they are completing the circuit across the heart which begins a recording session. Once the recording session is complete, the ECG App performs signal processing, feature extraction and rhythm classification to generate a session result.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sensitivity and specificity of the ECG App algorithmTime frame: One day visit

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.